| View |
|
DRP-9033-02
|
Levetiracetam
|
SEIZ OS
|
100mg/mL
|
Oral Solution
|
Antiepileptic
|
Hetero Labs Limited (Unit III)
|
India
|
CLIDP Conversion
|
13 September 2021
|
20 August 2025
|
| View |
|
DRP-11250-01
|
Cefuroxime (as sodium)
|
Levexime
|
750 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Swiss Parenterals Ltd.
|
India
|
CLIDP Conversion
|
07 July 2022
|
17 February 2027
|
| View |
|
DRP-12408-02
|
Cefalexin (as monohydrate)
|
Regilexin
|
250 mg/5 mL
|
Powder for Suspension
|
Antibacterial (First Generation Cephalosporins)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
03 October 2022
|
21 July 2027
|
| View |
|
DRP-9078-02
|
Sitagliptin (as phosphate)
|
None
|
50 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 July 2022
|
31 October 2025
|
| View |
|
DRP-11154-10
|
Nicardipine Hydrochloride
|
Nicmeed
|
1mg/mL (10mg/10mL)
|
Solution for Injection (IV Infusion)
|
Calcium Channel Blocker (Dihydropiridine derivative)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
01 August 2022
|
11 February 2027
|
| View |
|
DRP-10868-09
|
Ascorbic Acid + Zinc
|
Jil Cee
|
533.40 mg (equivalent to 600mg Sodium Ascorbate)+ 10mg (equivalent to 27.45mg Zinc Sulfate)
|
Capsule
|
Vitamin/Mineral
|
Eurasia Research Pharma Corporation
|
Philippines
|
CLIDP Conversion
|
12 October 2022
|
25 October 2025
|
| View |
|
DRP-9077-01
|
Fluticasone propionate
|
Flumist
|
50 mcg
|
Nasal Spray
|
Corticosteroid
|
World Medicine Ilaç Sanayi ve Ticaret A.?
|
Turkey
|
CLIDP Conversion
|
09 June 2022
|
15 September 2025
|
| View |
|
DRP-12408-01
|
Cefalexin (as monohydrate)
|
CEFARAP
|
250 mg/5 mL
|
Powder for Suspension
|
Antibacterial (First Generation Cephalosporins)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
28 September 2022
|
21 July 2027
|
| View |
|
DRP-11203-01
|
Anastrozole
|
None
|
1 mg
|
Film-Coated Tablet
|
Aromatase Inhibitor
|
Jodas Expoim Pvt. Ltd
|
India
|
CLIDP Conversion
|
21 June 2022
|
02 March 2027
|
| View |
|
DRP-263-05
|
Paracetamol + Ibuprofen
|
Prozet
|
325mg/200mg
|
Tablet
|
Analgesic/Antipyretic
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
12 April 2023
|
30 June 2028
|
| View |
|
DRP-11107-03
|
Ascorbic Acid + Zinc
|
InnoC + Z
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate) / 10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
CapsuleAlu/Deep Red PVC Blister Pack x 10's (Box of 10's, 30'sand 100's)
|
Vitamin / Mineral
|
Pharmatechnica Laboratory, Inc
|
Philippines
|
CLIDP Conversion
|
29 March 2022
|
02 February 2027
|
| View |
|
DRP-11620-02
|
Febuxostat
|
Febuwise
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Gracure Pharmaceutical Ltd.
|
India
|
CLIDP Conversion
|
12 July 2022
|
04 April 2027
|
| View |
|
DRP-4693-13
|
Losartan Potassium
|
Unbranded
|
100 mg
|
Film-Coated Tablet
|
Angiotensin-II-Receptor Blocker
|
Mediwin Pharmaceuticals
|
India
|
Renewal
|
13 December 2022
|
06 September 2028
|
| View |
|
DRP-6527-07
|
Meropenem (as Trihydrate)
|
Ropimed
|
1 g
|
Powder for Solution for Injection (IV)
|
Antibacterial (Carbapenem)
|
Zeiss Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
21 April 2022
|
12 February 2026
|
| View |
|
DRP-9391-01
|
Telmisartan
|
Telwin 80
|
80 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics & Chemicals Limited
|
India
|
CLIDP Conversion
|
23 September 2021
|
02 March 2026
|
| View |
|
DRP-9390-03
|
Telmisartan
|
Tel-S
|
40 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics & Chemicals Ltd.
|
India
|
CLIDP Conversion
|
22 September 2021
|
02 March 2026
|
| View |
|
DRP-10929-08
|
Norepinephrine (As Bitartrate)
|
Freeron
|
1mg/mL (4mg/4mL)
|
Solution For Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Mackur Laboratories Limited
|
India
|
Automatic Renewal
|
20 June 2022
|
31 January 2027
|
| View |
|
DRP-8586-14
|
Trimetazidine dihydrochloride
|
Xinprotec
|
35 mg
|
Modified-Release Tablet
|
Anti-Angina
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
25 April 2024
|
18 December 2029
|
| View |
|
DRP-10511-02
|
Febuxostat
|
Fexogout-80
|
80 mg
|
Film-Coated Tablet
|
Antigout
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 January 2022
|
07 October 2026
|
| View |
|
DRP-10929-04
|
Norepinephrine (As Bitartrate)
|
Neurophrine
|
1mg/mL (4mg/4mL)
|
Solution for Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Mackur Laboratories Limited
|
India
|
Automatic Renewal
|
12 May 2022
|
31 January 2027
|